204 related articles for article (PubMed ID: 16489073)
1. Association of S100A4 and osteopontin with specific prognostic factors and survival of patients with minimally invasive breast cancer.
de Silva Rudland S; Martin L; Roshanlall C; Winstanley J; Leinster S; Platt-Higgins A; Carroll J; West C; Barraclough R; Rudland P
Clin Cancer Res; 2006 Feb; 12(4):1192-200. PubMed ID: 16489073
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of the metastasis-inducing protein S100A4 (p9Ka) in human breast cancer.
Rudland PS; Platt-Higgins A; Renshaw C; West CR; Winstanley JH; Robertson L; Barraclough R
Cancer Res; 2000 Mar; 60(6):1595-603. PubMed ID: 10749128
[TBL] [Abstract][Full Text] [Related]
3. Induction of metastasis by S100P in a rat mammary model and its association with poor survival of breast cancer patients.
Wang G; Platt-Higgins A; Carroll J; de Silva Rudland S; Winstanley J; Barraclough R; Rudland PS
Cancer Res; 2006 Jan; 66(2):1199-207. PubMed ID: 16424059
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the metastasis-inducing protein S100A4 (p9ka) with other prognostic markers in human breast cancer.
Platt-Higgins AM; Renshaw CA; West CR; Winstanley JH; De Silva Rudland S; Barraclough R; Rudland PS
Int J Cancer; 2000 Mar; 89(2):198-208. PubMed ID: 10754500
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of the metastasis-associated protein osteopontin in human breast cancer.
Rudland PS; Platt-Higgins A; El-Tanani M; De Silva Rudland S; Barraclough R; Winstanley JH; Howitt R; West CR
Cancer Res; 2002 Jun; 62(12):3417-27. PubMed ID: 12067984
[TBL] [Abstract][Full Text] [Related]
6. Expression of S100A4 and Met: potential predictors for metastasis and survival in early-stage breast cancer.
Lee WY; Su WC; Lin PW; Guo HR; Chang TW; Chen HH
Oncology; 2004; 66(6):429-38. PubMed ID: 15452371
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of S100A4-expression and subcellular localization in early-stage breast cancer.
Egeland EV; Boye K; Park D; Synnestvedt M; Sauer T; ; Naume B; Borgen E; Mælandsmo GM
Breast Cancer Res Treat; 2017 Feb; 162(1):127-137. PubMed ID: 28058579
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of S100A4 expression in gallbladder cancer.
Nakamura T; Ajiki T; Murao S; Kamigaki T; Maeda S; Ku Y; Kuroda Y
Int J Oncol; 2002 May; 20(5):937-41. PubMed ID: 11956586
[TBL] [Abstract][Full Text] [Related]
9. Expression of S100A4, E-cadherin, alpha- and beta-catenin in breast cancer biopsies.
Pedersen KB; Nesland JM; Fodstad Ø; Maelandsmo GM
Br J Cancer; 2002 Nov; 87(11):1281-6. PubMed ID: 12439718
[TBL] [Abstract][Full Text] [Related]
10. Expression of S100A4 protein is associated with metastasis and reduced survival in human bladder cancer.
Davies BR; O'Donnell M; Durkan GC; Rudland PS; Barraclough R; Neal DE; Mellon JK
J Pathol; 2002 Mar; 196(3):292-9. PubMed ID: 11857492
[TBL] [Abstract][Full Text] [Related]
11. Combined expression of S100A4 and Annexin A2 predicts disease progression and overall survival in patients with urothelial carcinoma.
Zhang Q; Zhao Z; Ma Y; Wang H; Ma J; He X; Zhang D
Urol Oncol; 2014 Aug; 32(6):798-805. PubMed ID: 24968947
[TBL] [Abstract][Full Text] [Related]
12. S100A4 expression is a prognostic indicator in small intestine adenocarcinoma.
Roh J; Knight S; Chung JY; Eo SH; Goggins M; Kim J; Cho H; Yu E; Hong SM
J Clin Pathol; 2014 Mar; 67(3):216-21. PubMed ID: 24062356
[TBL] [Abstract][Full Text] [Related]
13. Expression of S100A2 and S100A4 predicts for disease progression and patient survival in bladder cancer.
Matsumoto K; Irie A; Satoh T; Ishii J; Iwabuchi K; Iwamura M; Egawa S; Baba S
Urology; 2007 Sep; 70(3):602-7. PubMed ID: 17688917
[TBL] [Abstract][Full Text] [Related]
14. S100A4 promotes invasion and angiogenesis in breast cancer MDA-MB-231 cells by upregulating matrix metalloproteinase-13.
Wang L; Wang X; Liang Y; Diao X; Chen Q
Acta Biochim Pol; 2012; 59(4):593-8. PubMed ID: 23162804
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic significance of S100A4 expression in osteosarcoma.
Cao CM; Yang FX; Wang PL; Yang QX; Sun XR
Eur Rev Med Pharmacol Sci; 2014; 18(6):833-9. PubMed ID: 24706307
[TBL] [Abstract][Full Text] [Related]
16. Significance of the Fanconi anemia FANCD2 protein in sporadic and metastatic human breast cancer.
Rudland PS; Platt-Higgins AM; Davies LM; de Silva Rudland S; Wilson JB; Aladwani A; Winstanley JH; Barraclough DL; Barraclough R; West CR; Jones NJ
Am J Pathol; 2010 Jun; 176(6):2935-47. PubMed ID: 20363922
[TBL] [Abstract][Full Text] [Related]
17. Prognostic values of osteopontin-c, E-cadherin and β-catenin in breast cancer.
Pang H; Lu H; Song H; Meng Q; Zhao Y; Liu N; Lan F; Liu Y; Yan S; Dong X; Cai L
Cancer Epidemiol; 2013 Dec; 37(6):985-92. PubMed ID: 24012693
[TBL] [Abstract][Full Text] [Related]
18. Estrogen receptor beta--an independent prognostic marker in estrogen receptor alpha and progesterone receptor-positive breast cancer?
Maehle BO; Collett K; Tretli S; Akslen LA; Grotmol T
APMIS; 2009 Sep; 117(9):644-50. PubMed ID: 19703124
[TBL] [Abstract][Full Text] [Related]
19. Metastasis-associated protein S100A4--a potential prognostic marker for colorectal cancer.
Hemandas AK; Salto-Tellez M; Maricar SH; Leong AF; Leow CK
J Surg Oncol; 2006 May; 93(6):498-503. PubMed ID: 16615153
[TBL] [Abstract][Full Text] [Related]
20. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.
Saha B; Zhang N; Naritoku WY; Tsao-Wei DD; Groshen SL; Carlsson G; Larsson L; Gustavsson B; Chaiwun B; Taylor CR; Imam SA
Anticancer Res; 2004; 24(4):2391-400. PubMed ID: 15330189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
